Detailed description page of AntiTbPdb
| This page displays user query in tabular form. |
antitb_1691 details |
| Primary information | |
|---|---|
| ID | antitb_1691 |
| Peptide Name | Takaokamycin |
| Sequence | not available |
| N-terminal Modification | NA |
| C-terminal Modification | NA |
| Chemical Modification | None |
| Linear/ Cyclic | NA |
| Length | 0 |
| Chirality | NA |
| Nature | NA |
| Source | Natural |
| Origin | Streptomyces sp. AC-1978, |
| Species | Mycobacterium smegmatis |
| Strain | Mycobacterium smegmatis ATCC 607 |
| Inhibition Concentartion | MIC = >100 μg/ml |
| In vitro/In vivo | in vitro |
| Cell Line | NA |
| Inhibition Concentartion | NA |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Response | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other Activities | Staphylococcus aureus ATCC 6538P, S. aureus FDA 209P, Bacillus subtilis ATCC 6633, B. cereus IFO 3001, Micrococcus luteus ATCC 9341, Escherichia coli NIHJ, E. coli NIHJ JC-2, Klebsiella pneumoniae ATCC 10031, Proteus vulgaris IFO 3167, Pseudomonas aeruginosa IFO 3080 |
| Pubmed ID | 6732903 |
| Year of Publication | 1984 |
| 3-D Structure | NA |